Morgan Stanley Eli Lilly & CO Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Eli Lilly & CO stock. As of the latest transaction made, Morgan Stanley holds 14,556,142 shares of LLY stock, worth $11.6 Billion. This represents 0.95% of its overall portfolio holdings.

Number of Shares

14,556,142

Previous 13,722,003 6.08%

Holding current value

$11.6 Billion

Previous $12.4 Billion 3.8%

% of portfolio

0.95%

Previous 0.98%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $644 Million - $801 Million	834,139 Added 6.08%	14,556,142 $12.9 Billion
Q2 2024 Oct 17, 2024	BUY	$724.87 - $909.04 $473 Million - $593 Million	652,440 Added 4.99%	13,722,003 $12.4 Billion
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $473 Million - $593 Million	652,440 Added 4.99%	13,722,003 $12.4 Billion
Q1 2024 Oct 17, 2024	SELL	$592.2 - $792.28 $386 Million - $517 Million	-652,440 Reduced 4.75%	13,069,563 $10.2 Billion
Q1 2024 Aug 16, 2024	BUY	$592.2 - $792.28 $242 Million - $324 Million	408,846 Added 3.23%	13,069,563 $10.2 Billion
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $242 Million - $324 Million	408,846 Added 3.23%	13,069,563 $10.2 Billion
Q4 2023 Aug 16, 2024	SELL	$525.19 - $619.13 $557 Million - $657 Million	-1,061,286 Reduced 7.73%	12,660,717 $7.38 Billion
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $60.5 Million - $71.3 Million	115,145 Added 0.92%	12,660,717 $7.38 Billion
Q3 2023 Nov 15, 2023	BUY	$434.7 - $599.3 $36.5 Million - $50.3 Million	83,915 Added 0.67%	12,545,572 $6.74 Billion
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $112 Million - $149 Million	318,198 Added 2.62%	12,461,657 $5.84 Billion
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $26.2 Million - $30.7 Million	84,255 Added 0.7%	12,143,459 $4.17 Billion
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $1.19 Billion - $1.38 Billion	3,691,436 Added 44.11%	12,059,204 $4.41 Billion
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $256 Million - $292 Million	864,625 Added 11.52%	8,367,768 $2.71 Billion
Q2 2022 Oct 27, 2022	BUY	$278.73 - $327.27 $984 Million - $1.16 Billion	3,529,744 Added 88.83%	7,503,143 $2.43 Billion
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $984 Million - $1.16 Billion	3,529,744 Added 88.83%	7,503,143 $2.43 Billion
Q1 2022 Oct 27, 2022	SELL	$234.69 - $291.66 $828 Million - $1.03 Billion	-3,529,744 Reduced 47.04%	3,973,399 $1.14 Billion
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $35.3 Million - $43.9 Million	150,539 Added 3.94%	3,973,399 $1.14 Billion
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $10.1 Million - $12.5 Million	44,831 Added 1.19%	3,822,860 $1.06 Billion
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $837 Million - $1.03 Billion	3,778,029 New	3,778,029 $873 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account